Zobrazeno 1 - 10
of 289
pro vyhledávání: '"Andrés F. Cardona"'
Autor:
Carolina Sotelo-Rodríguez, Dora Vallejo-Ardila, Alejandro Ruiz-Patiño, Diego F. Chamorro, July Rodríguez, Darwin A. Moreno-Pérez, Hernán Carranza, Jorge Otero, Carlos Vargas, Pilar Archila, Leonardo Rojas, Jairo Zuluaga, Cladelis Rubio, Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Sergio Mejía, Elvira Jaller, Oscar Arrieta, Andrés F. Cardona
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEMultidisciplinary molecular tumor boards (MTBs) decode complex genomic data into clinical recommendations. Although MTBs are well-established in the oncology practice in developed countries, this strategy needs to be better explored in develop
Externí odkaz:
https://doaj.org/article/f1edd971456a455fbf30923dfbc441e5
Autor:
Alejandro Avilés-Salas, Luis Cabrera-Miranda, Norma Hernández-Pedro, Diana Sofía Vargas-Lías, Suraj Samtani, Wendy Muñoz-Montaño, Daniel Motola-Kuba, Luis Corrales-Rodríguez, Claudio Martín, Andrés F. Cardona, Cittim B. Palomares-Palomares, Oscar Arrieta
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundProgrammed death ligand-1 (PD-L1) expression is a predictive biomarker in patients with lung cancer, but its role in malignant pleural mesothelioma (MPM) remains unclear. Evidence suggests that higher PD-L1 expression is correlated with wor
Externí odkaz:
https://doaj.org/article/8c55a8d1b8f84fa4aee228acd9b565c9
Autor:
Leonardo Rojas, María X. Rojas-Reyes, Diego Rosselli, Juan Guillermo Ariza, Alejandro Ruiz-Patiño, Andrés F. Cardona
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background In Colombia, the best strategy to establish indication for adjuvant chemotherapy in early breast cancer (EBC) remains unknown. This study aimed to identify the cost-utility of Oncotype DX™ (ODX) or Mammaprint™ (MMP) tests to e
Externí odkaz:
https://doaj.org/article/587cc92b58614f9aa3c2802d8edb0e81
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 6, Iss 4, Pp 185-186 (2023)
Externí odkaz:
https://doaj.org/article/ac2696e14b8d4b7087eb74c613ea77a7
Autor:
Oscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, Luis Lara-Mejía, Jenny G. Turcott, Salvador Gutiérrez, Francisco Lozano-Ruiz, Luis Cabrera-Miranda, Andrés Mauricio Arroyave-Ramírez, Federico Maldonado-Magos, Luis Corrales, Claudio Martín, Ana Pamela Gómez-García, Bernardo Cacho-Díaz, Andrés F. Cardona
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundDifferent prognostic scales exist in patients with brain metastasis, particularly in lung cancer. The Graded Prognostic Assessment for lung cancer using molecular markers (Lung-molGPA index) for brain metastases is a powerful prognostic too
Externí odkaz:
https://doaj.org/article/014ecf5839d84666b3f0118f41988555
Autor:
Daniela Cárdenas-Fernández, Pamela Soberanis Pina, Jenny G. Turcott, Norberto Chávez-Tapia, Emilio Conde-Flores, Andrés F. Cardona, Oscar Arrieta
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
The identification of Epidermal Growth Factor Receptor (EGFR) mutations in lung adenocarcinoma has facilitated the development of personalized medicine based on oncogenic drivers. EGFR-Tyrosine Kinase Inhibitors (TKIs) are part of the targeted therap
Externí odkaz:
https://doaj.org/article/e51a7bd2e4b2499ea2a8155add3c3e41
Autor:
Salvador Gutierrez Torres, Federico Maldonado Magos, Jenny G. Turcott, Juan‐Manuel Hernandez‐Martinez, Bernardo Cacho‐Díaz, Andrés F. Cardona, Aida Mota‐García, Francisco Lozano Ruiz, Maritza Ramos‐Ramirez, Oscar Arrieta
Publikováno v:
Cancer Medicine, Vol 12, Iss 1, Pp 146-158 (2023)
Abstract Background Most studies evaluating factors associated with the survival of patients with brain metastases (BM) have focused on patients with newly diagnosed BM. This study aimed to identify prognostic factors associated with survival after b
Externí odkaz:
https://doaj.org/article/d165a5944bf64f57bdbca148ab5cf741
Autor:
Alejandro Avilés-Salas, Diego A. Díaz-García, Luis Lara-Mejía, Andrés F. Cardona, Mario Orozco-Morales, Rodrigo Catalán, Norma Y. Hernández-Pedro, Eduardo Rios-Garcia, Maritza Ramos-Ramírez, Oscar Arrieta
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 333-343 (2022)
(1) Background: Liver kinase B1 (LKB1) is a tumor suppressor gene involved in cell growth and metabolism. However, its alterations are not routinely assessed for guiding therapy in clinical practice. We assessed LKB1 expression by immunohistochemistr
Externí odkaz:
https://doaj.org/article/6d051a4228fc434cb2e0e286fad4a2e5
Autor:
Alejandro Cañas, Enrique Jiménez, Fernando Hakim, Juan Armando Mejía, Juan Fernando Ramón, Diego Gómez, Daniel Jaramillo-Velásquez, Sonia Bermúdez, Nicolás Useche, Diego Pineda, Hernando Cifuentes, Antonio Becerra, Álvaro Muñoz, Nicolás Santoyo, Alejandro Ruíz-Patiño, Carolina Sotelo, Pilar Archila, July Rodríguez, Jenny Ávila, Camila Ordoñez-Reyes, Juan Esteban García-Robledo, Luisa Ricaurte, Leonardo Rojas, Oscar Feo, Remberto Burgos, Carlos Ramírez, Oscar Arrieta, Lucía Zatarain-Barrón, Carlos Vargas, Hernán Carranza, Jorge Otero, Andrés F. Cardona
Publikováno v:
Biomédica: revista del Instituto Nacional de Salud, Vol 42, Iss 4, Pp 574-590 (2022)
Introducción. En los meningiomas, ocurren con frecuencia mutaciones en la región promotora de la transcriptasa inversa de la telomerasa. Objetivo. Estimar la importancia pronóstica de las mutaciones de la transcriptasa inversa de la telomerasa en
Externí odkaz:
https://doaj.org/article/a8de1c0e48404393b50d092559d456db
Autor:
Alejandro Avilés‐Salas, Diana Flores‐Estrada, Luis Lara‐Mejía, Rodrigo Catalán, Graciela Cruz‐Rico, Mario Orozco‐Morales, David Heredia, Laura Bolaño‐Guerra, Pamela Denisse Soberanis‐Piña, Edgar Varela‐Santoyo, Andrés F. Cardona, Oscar Arrieta
Publikováno v:
Thoracic Cancer, Vol 13, Iss 23, Pp 3362-3373 (2022)
Abstract Background Programmed death ligand‐1 (PD‐L1) expression predicts immunotherapy utility in nononcogenic addictive lung adenocarcinoma (ADC). However, its reproducibility and reliability may be compromised outside clinical trials. This stu
Externí odkaz:
https://doaj.org/article/ab7624f0becc45a988ce49574b7ebcc8